Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1991 1
1992 2
1993 1
1997 1
1998 1
1999 1
2001 1
2002 2
2003 3
2004 1
2005 2
2006 2
2007 3
2008 3
2009 1
2010 7
2011 8
2012 7
2013 11
2014 11
2015 9
2016 10
2017 16
2018 18
2019 10
2020 18
2021 18
2022 17
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
Morotti H, Mastel S, Keller K, Barnard RA, Hall T, O'Roak BJ, Fombonne E. Morotti H, et al. Dev Med Child Neurol. 2021 Feb;63(2):226-232. doi: 10.1111/dmcn.14558. Epub 2020 May 14. Dev Med Child Neurol. 2021. PMID: 32406525 Free article.
INTERPRETATION: Our results do not support an association between NF1 and autism, both at the symptom and disorder levels. WHAT THIS PAPER ADDS: Diagnoses of attention-deficit/hyperactivity disorder (ADHD) were more common in children with neurofibromatosi …
INTERPRETATION: Our results do not support an association between NF1 and autism, both at the symptom and disorder levels. WHA …
Autism medical comorbidities.
Al-Beltagi M. Al-Beltagi M. World J Clin Pediatr. 2021 May 9;10(3):15-28. doi: 10.5409/wjcp.v10.i3.15. eCollection 2021 May 9. World J Clin Pediatr. 2021. PMID: 33972922 Free PMC article.
Medical comorbidities are more common in children with autism spectrum disorders (ASD) than in the general population. Some genetic disorders are more common in children with ASD such as Fragile X syndrome, Down syndrome, Duchenne muscular dystrophy, neurofibromatosis …
Medical comorbidities are more common in children with autism spectrum disorders (ASD) than in the general population. Some genetic d …
Phelan-McDermid Syndrome.
Phelan K, Rogers RC, Boccuto L. Phelan K, et al. 2005 May 11 [updated 2018 Jun 7]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2005 May 11 [updated 2018 Jun 7]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301377 Free Books & Documents. Review.
Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder or autistic-like affect and behavior. DIAGNOSIS/TESTING: The diagnosis of Phelan-McDermid syndrome is established in a proband with …
Behavior characteristics include mouthing or chewing non-food items, decreased perception of pain, and autism spectrum disorder …
An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.
Smith TF, Kaczorowski JA, Acosta MT. Smith TF, et al. Childs Nerv Syst. 2020 Oct;36(10):2321-2332. doi: 10.1007/s00381-020-04745-w. Epub 2020 Jul 3. Childs Nerv Syst. 2020. PMID: 32617712 Review.
PURPOSE: Neurofibromatosis type 1 (NF1) is a rare monogenic disorder associated with executive function (EF) deficits and heightened risk for attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). ...
PURPOSE: Neurofibromatosis type 1 (NF1) is a rare monogenic disorder associated with executive function (EF) deficits and heig …
An update on the central nervous system manifestations of neurofibromatosis type 1.
Nix JS, Blakeley J, Rodriguez FJ. Nix JS, et al. Acta Neuropathol. 2020 Apr;139(4):625-641. doi: 10.1007/s00401-019-02002-2. Epub 2019 Apr 8. Acta Neuropathol. 2020. PMID: 30963251 Free PMC article. Review.
Neurofibromatosis 1 (NF1) is an autosomal dominant genetic disorder that presents with variable phenotypes as a result of mutations in the neurofibromatosis type 1 (NF1) gene and subsequently, abnormal function of the protein product, neurofibromin. ...A vari …
Neurofibromatosis 1 (NF1) is an autosomal dominant genetic disorder that presents with variable phenotypes as a result of muta …
Autism Symptoms in Children and Young Adults With Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis Complex, and Neurofibromatosis Type 1: A Cross-Syndrome Comparison.
Lubbers K, Stijl EM, Dierckx B, Hagenaar DA, Ten Hoopen LW, Legerstee JS, de Nijs PFA, Rietman AB, Greaves-Lord K, Hillegers MHJ, Dieleman GC, Mous SE; ENCORE Expertise Center. Lubbers K, et al. Front Psychiatry. 2022 May 16;13:852208. doi: 10.3389/fpsyt.2022.852208. eCollection 2022. Front Psychiatry. 2022. PMID: 35651825 Free PMC article.
OBJECTIVE: The etiology of autism spectrum disorder (ASD) remains unclear, due to genetic heterogeneity and heterogeneity in symptoms across individuals. ...METHODS: We assessed ASD symptom severity in children and young adults (aged 0-28 years) with Fragile X Syndr …
OBJECTIVE: The etiology of autism spectrum disorder (ASD) remains unclear, due to genetic heterogeneity and heterogeneity in s …
Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.
Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, Green J. Garg S, et al. Dev Med Child Neurol. 2013 Feb;55(2):139-145. doi: 10.1111/dmcn.12043. Epub 2012 Nov 16. Dev Med Child Neurol. 2013. PMID: 23163236 Free article.
AIM: To investigate psychopathology in children with neurofibromatosis type 1 (NF1), particularly the prevalence of autism spectrum disorder (ASD) and attention-deficit-hyperactivity disorder (ADHD) symptomatology, using a population-based sampling app …
AIM: To investigate psychopathology in children with neurofibromatosis type 1 (NF1), particularly the prevalence of autism spe …
Neurofibromatosis type 1 and autism spectrum disorder.
Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, Huson SM. Garg S, et al. Pediatrics. 2013 Dec;132(6):e1642-8. doi: 10.1542/peds.2013-1868. Epub 2013 Nov 4. Pediatrics. 2013. PMID: 24190681
OBJECTIVE: To determine the prevalence of autism spectrum disorder (ASD) in Neurofibromatosis Type 1 (NF1). ...Twenty-three cases from the significant ASD group, 16 from moderate ASD, and 8 from non-ASD (total n = 47), invited proportionately by random select …
OBJECTIVE: To determine the prevalence of autism spectrum disorder (ASD) in Neurofibromatosis Type 1 (NF1). ...Twenty-t …
Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM, Pride NA, Walsh KS, Chisholm A, Rouel M, Maier A, Anderson V, Barton B, Silk T, Korgaonkar M, Seal M, Lami F, Lorenzo J, Williams K, Dabscheck G, Rae CD, Kean M, North KN, Payne JM. Haebich KM, et al. BMJ Open. 2019 Sep 26;9(9):e030601. doi: 10.1136/bmjopen-2019-030601. BMJ Open. 2019. PMID: 31558455 Free PMC article.
INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. ...Chil …
INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for a …
Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.
Payne JM, Walsh KS, Pride NA, Haebich KM, Maier A, Chisholm A, Glad DM, Casnar CL, Rouel M, Lorenzo J, Del Castillo A, North KN, Klein-Tasman B. Payne JM, et al. Dev Med Child Neurol. 2020 Jul;62(7):813-819. doi: 10.1111/dmcn.14517. Epub 2020 Mar 17. Dev Med Child Neurol. 2020. PMID: 32181506 Free article.
AIM: We examined key features of two outcome measures for social dysfunction and autism spectrum disorder traits, the Social Responsiveness Scale, Second Edition (SRS-2) and the Social Skills Improvement System - Rating Scales (SSIS-RS), in children with neurofib …
AIM: We examined key features of two outcome measures for social dysfunction and autism spectrum disorder traits, the Social R …
159 results